GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » iDNA Genomics Public Ltd (CYS:IDNA) » Definitions » ROCE %

iDNA Genomics Public (CYS:IDNA) ROCE % : 0.00% (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is iDNA Genomics Public ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. iDNA Genomics Public's annualized ROCE % for the quarter that ended in . 20 was 0.00%.


iDNA Genomics Public ROCE % Historical Data

The historical data trend for iDNA Genomics Public's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iDNA Genomics Public ROCE % Chart

iDNA Genomics Public Annual Data
Trend
ROCE %

iDNA Genomics Public Semi-Annual Data
ROCE %

iDNA Genomics Public ROCE % Calculation

iDNA Genomics Public's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( (+)/ )
=/
= %

iDNA Genomics Public's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( ( + )/ )
=/
= %

(1) Note: The EBIT data used here is one times the annual (. 20) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iDNA Genomics Public  (CYS:IDNA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


iDNA Genomics Public ROCE % Related Terms

Thank you for viewing the detailed overview of iDNA Genomics Public's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


iDNA Genomics Public Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Evrota 25- 27, Kifissia, GRC, 145 64
iDNA Genomics Public Ltd is engaged in performing precision medicine and genetic analysis (DNA Tests). Its focus is on developing and providing Genetic Testing Analysis both in Medical and Direct-To-Consumer Genomics sectors, with research activity through cooperation with universities in Greece and abroad.

iDNA Genomics Public Headlines